Maintenance agreement facs vantage SE, serial #SE0274
Ended Awarded Last action
- Contract number
- HHSGS24F2044DHHSN26100914
- Awardee
-
Becton, Dickinson And Company UEI MM5ZHL8SRFY5 Part of Becton, Dickinson And Co
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $38,628
Award facts
- Contract value 100% obligated
- $38,628.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6630 Chemical Analysis Instruments
- Set-aside
- No set-aside
- Competition
- Non-Competitive Delivery Order · 1 offer
- Pricing
- Firm Fixed Price
- Place of performance
- Maryland, USA
Award details come from SAM.gov/FPDS.
About this award
Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, was awarded a delivery order contract on October 1, 2003, for maintenance services on a FACS Vantage SE flow cytometry instrument (Serial #SE0274). This firm fixed-price contract, valued at $38,628, is scheduled for completion by September 30, 2004, and will be performed in Maryland. The contract was awarded on a full and open competitive basis without a small business set-aside designation, consistent with BD's established position as a major supplier of sophisticated biomedical research equipment and services to federal agencies.
BD Biosciences is a global medical technology manufacturer specializing in flow cytometry systems, cell imaging technologies, and associated reagents and support services. The company maintains an extensive federal contract portfolio with multiple agencies including the Department of Veterans Affairs, National Institutes of Health, and the Centers for Disease Control and Prevention. This maintenance agreement represents a typical component of BD's service offerings to government healthcare and research institutions, supporting the continued operational capability of critical laboratory instrumentation used across federal research and clinical settings.
Quick answers
Who was awarded contract HHSGS24F2044DHHSN26100914?
HHSGS24F2044DHHSN26100914 was awarded to Becton, Dickinson And Company by National Cancer Institute (National Institutes of Health) on October 1, 2003.
How much is contract HHSGS24F2044DHHSN26100914 worth?
The government has obligated $38,628 on HHSGS24F2044DHHSN26100914.
Is contract HHSGS24F2044DHHSN26100914 an order under another contract?
Yes. HHSGS24F2044DHHSN26100914 is a delivery order under GS24F2044D, a federal supply schedule.
Was contract HHSGS24F2044DHHSN26100914 competed?
The extent of competition for HHSGS24F2044DHHSN26100914 was non-competitive delivery order. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award